Position in AKBA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$88,910
+$21,276 QoQ
Shares Held
77,992
+60.3% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#73
of 170 holders
Holding Since
Mar 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Headlands Technologies LLC holds $12,343,549 across 11 Drug Manufacturers - Specialty & Generic names. AKBA ranks #9 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
8,228 | $4,458,177 | |
| 2 | ZTS |
Zoetis Inc.
|
55,106 | $3,959,917 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
18,161 | $1,161,395 | |
| 4 | ALKS |
Alkermes plc.
|
14,313 | $750,001 | |
| 5 | TLRY |
Tilray Brands, Inc.
|
160,665 | $721,385 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
45,351 | $453,510 | |
| 7 | CRON |
Cronos Group Inc.
|
127,364 | $354,071 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
6,535 | $303,942 |
All Filings in AKBA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $88,910 | 77,992 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $67,634 | 48,658 | Shares | Sole | 2026-05-13 | |
| 2025-06-30 | $4,564 | 1,254 | Shares | Sole | 2025-08-14 | |
| 2024-06-30 | $212 | 208 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $5,008 | 2,737 | Shares | Sole | 2024-05-07 | |
| No filing history on record for this holder in this stock. | ||||||